Predictive biomarkers and patient outcome in platinum-resistant (PLD-treated) ovarian cancer

Identification of predictive biomarkers for ovarian cancer (OC) treatment, particularly in the platinum-resistant/refractory setting, is highly relevant for clinical management. E-cadherin, vimentin, and osteopontin (OPN) are proteins associated with tumor microenvironment (TME) remodelling that pla...

ver descrição completa

Detalhes bibliográficos
Autor principal: Sousa, IJD (author)
Outros Autores: Marques, DS (author), Príncipe, C (author), Portugal, RV (author), Canberk, S (author), Prazeres, H (author), Lopes, JM (author), Gimba, ERP (author), Lima, RT (author), Soares, P (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
E-cadherin
Osteopontin
Osteopontin-c
Ovarian cancer
Predictive biomarkers
Prognostic biomarkers
Tumor microenvironment
Vimentin
Texto completo:https://hdl.handle.net/10216/143542
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/143542

Texto Completo

https://hdl.handle.net/10216/143542

Registos relacionados